DOMPE
Lidia De Filippis is a seasoned professional in the fields of toxicology, pharmacology, and neuroscience, currently serving as a Preclinical Toxicology and Pharmacology Senior Manager at Dompé since February 2019. In this role, Lidia supports the Chief Medical Officer and oversees strategic collaborations between Preclinical and Clinical/Medical teams to advance therapeutic developments. Previous experience includes a PhD researcher position at ISBREMIT, where Lidia contributed to regenerative medicine research, and a visiting researcher role at the Child Health Institute of New Jersey focused on the neural induction of iPS cells related to alcohol addiction and autism disorders. Lidia's earlier positions include training roles at Casa Sollievo della Sofferenza and a biologist position at Università degli Studi di Milano-Bicocca, where Lidia engaged in studies on human neural stem cell transplantation for neurodegenerative diseases. Lidia holds a Doctor of Philosophy (PhD) in Neuroscience from The Open University.
DOMPE
2 followers
DOMPE is a biopharmaceutical company that is committed to research and development to meet unsatisfied therapeutic needs. The company's products are engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personalhygiene. The therapeutic areas include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmic, stomatology, and respiratory.Founded in 1940, Dompe is headquartered in Milan, Italy.